Related Experiment Video
Updated: Aug 14, 2026
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
New strategies for active immunotherapy with genetically engineered tumor cells
1Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2196.
Current Opinion in Immunology
|October 1, 1992
Summary
Genetically engineering tumor cells to secrete cytokines offers a promising cancer vaccine strategy. This approach enhances local immune responses and systemic antitumor immunity with minimal toxicity.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Previous tumor vaccine strategies have faced challenges in achieving clear efficacy in human trials.
- Newer approaches involve genetically modifying tumor cells to express antigens or secrete cytokines.
Purpose of the Study:
- To explore the potential of engineering tumor cells to secrete cytokines for enhanced cancer immunotherapy.
- To investigate the mechanisms by which paracrine cytokine secretion can induce local and systemic antitumor effects.
Main Methods:
- Genetic modification of tumor cells in animal models.
- Engineering tumor cells to secrete specific cytokines.
- Assessment of local inflammatory responses and systemic antitumor immunity.
Main Results:
- Engineered tumor cells secreting cytokines induced potent local effects without significant systemic toxicity.
- This approach enhanced tumor antigen presentation and T lymphocyte activation.
- Systemic antitumor immunity was observed, suggesting a viable therapeutic strategy.
Conclusions:
- Engineering tumor cells to secrete cytokines represents a novel and effective strategy for cancer vaccines.
- This method holds promise for improving cancer immunotherapy by harnessing local and systemic immune responses.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...